Pregnancy and fetal outcomes following maternal use of glatiramer acetate

Researchers from Teva Pharmaceuticals and St. Josef-Hospital (Bochum, Germany) have published the pregnancy and fetal outcomes for a cohort of 618 women who used glatiramer acetate in all three trimesters of pregnancy. More information can be found here.